RESUMEN
No disponible
Asunto(s)
Humanos , Masculino , Anciano de 80 o más Años , Mycobacterium bovis/aislamiento & purificación , Administración Intravesical , Aortitis/diagnóstico por imagen , Tuberculosis/diagnóstico , Dolor Abdominal/diagnóstico por imagen , Dolor Abdominal/etiología , Aortitis/patología , Pruebas de Sensibilidad Microbiana/métodos , Neoplasias de la Vejiga UrinariaAsunto(s)
Aortitis/diagnóstico , Vacuna BCG/efectos adversos , Mycobacterium bovis/aislamiento & purificación , Tuberculosis/diagnóstico , Administración Intravesical , Anciano de 80 o más Años , Aorta Abdominal/diagnóstico por imagen , Aorta Abdominal/microbiología , Aortitis/etiología , Vacuna BCG/administración & dosificación , Ecocardiografía , Humanos , Masculino , Tomografía Computarizada por Rayos X , Tuberculosis/etiologíaAsunto(s)
Telangiectasia Hemorrágica Hereditaria/diagnóstico por imagen , Telangiectasia Hemorrágica Hereditaria/cirugía , Angiografía , Malformaciones Arteriovenosas/complicaciones , Malformaciones Arteriovenosas/diagnóstico por imagen , Malformaciones Arteriovenosas/cirugía , Cianosis/complicaciones , Procedimientos Endovasculares , Epistaxis/complicaciones , Femenino , Humanos , Arteria Pulmonar/anomalías , Arteria Pulmonar/diagnóstico por imagen , Arteria Pulmonar/patología , Venas Pulmonares/anomalías , Venas Pulmonares/diagnóstico por imagen , Venas Pulmonares/patología , Telangiectasia Hemorrágica Hereditaria/complicaciones , Tomografía Computarizada por Rayos X , Adulto JovenRESUMEN
UNLABELLED: FUNDAMENTAL AND OBJECTIVE: To present the first experiences with a series of consecutive cases of patients with non-small cell lung cancer (NSCLC) treated with radiofrequency ablation (RFA), considering its clinical applicability, effectiveness and safety. PATIENTS AND METHODS: Descriptive study performed from June 2003 to March 2009, with a series of consecutive cases of patients with NSCLC treated with RFA, selected according to well-defined inclusion criteria, in different stages of the disease. The variables studied were local recurrence, complications, staging, demographic and procedure-related variables. Local control was assessed in posterior controls according to CT morphology criteria and/or lesion enhancement after intravenous contrast. Survival curves were estimated. Statistical analysis was performed with SPSS version 15.0 application. RESULTS: We studied 15 patients (46-88 years), diagnosed with NSCLC in different stages, in a total of 22 sessions. After 1 year of follow up, 75% of lesions showed no local recurrence (15). The progression-free survival and disease-free survival in localized stage at one year were 81,3% and 75% respectively. In 8 of 22 sessions there were post-procedure complications (36.36%). Of all complications (14), 28.5% were pneumothorax, 21.4% alveolar hemorrhage and 7.1% pulmonary infarction. CONCLUSION: ARF is clinically useful in the treatment of patients with inoperable NSCLC, considering the high percentage of local control and few major complications, being thus a plausible, effective and safe therapeutic alternative.